以岭药业 (002603)

SHIJIAZHUANG YILING PHARMACEUTICAL CO.,LTD

ASZ

Tags

Generic DrugsElderly Care ConceptInnovative DrugsPharmaceutical ManufacturingFace Mask ProtectionGene ConceptHelicobacter PyloriSmart HealthcareWearable DevicesBiological VaccinesHigh-Performing StocksMargin Trading and Securities LendingSME 100 IndexSME 300 IndexSZSE 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 167070.54
  • Circulating A-Shares(W): 137684.67
  • Earnings Per Share(RMB): 0.5988
  • Net Assets Per Share(RMB): 6.4068
  • Operating Revenue(W RMB): 586760.31
  • Total Profit(W RMB): 116963.54
  • Net Profit Attributable to Parent(W RMB): 100040.47
  • Net Profit Growth Rate(%): 80.33
  • Weighted Return on Equity(%): 9.3400
  • Operating Cash Flow Per Share(RMB): 0.7650
  • Undistributed Profit Per Share(RMB): 3.4593
  • Capital Reserve Per Share(RMB): 1.3909

2. Main Business

The main business covers:

  • R&D, production and sales of patented innovative traditional Chinese medicine

3. Company Basic Information

  • Company Name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
  • Listing Date: 2011-07-28
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 238 Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province
  • Website: www.yiling.cn
  • Company Profile: According to the resolution of Yiling Co., Ltd.'s shareholders' meeting and approved by the Hebei Provincial People's Government's "Reply on Approving the Change and Establishment of Shijiazhuang Yiling Pharmaceutical Co., Ltd." (Ji Gu Ban [2001] No. 90), Yiling Co., Ltd. was restructured and established as Shijiazhuang Yiling Pharmaceutical Co., Ltd. on August 28, 2001, using the audited net asset value of 79,866,655.57 yuan as of May 31, 2001, converted into 79,866,000 shares of the company, with the remaining 655.57 yuan as capital reserve. Zhongqin Wanxin Certified Public Accountants issued the "Capital Verification Report" (2001) Qin Xin Yan Zi No. 08021. On the same day, the company obtained the "Business License" issued by the Hebei Provincial Administration for Industry and Commerce, with registration number 1300001001986.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Yiling Pharmaceutical Technology Co., Ltd. General Legal Person 52677.60 38.26
2 Hong Kong Securities Clearing Company Ltd. Northbound Capital 2570.40 1.87
3 CSI 500 Exchange Traded Open-End Index Securities Investment Fund Fund 1213.96 0.88
4 Changxin Jinli Trend Hybrid Securities Investment Fund Class A Fund 595.00 0.43
5 Ping An Fund - Ping An Life Insurance Company of China, Ltd. - Dividend - Individual Insurance Dividend - Ping An Life - Ping An Fund Equity Entrusted Investment No. 2 Single Asset Management Plan Asset Management Plan 536.40 0.39
6 ChinaAMC CSI Traditional Chinese Medicine Exchange Traded Open-End Index Securities Investment Fund Fund 521.06 0.38
7 Qianhai Kaiyuan Traditional Chinese Medicine Research Selected Stock Initiated Securities Investment Fund Class A Fund 355.21 0.26
8 Penghua CSI Traditional Chinese Medicine Exchange Traded Open-End Index Securities Investment Fund Fund 199.07 0.14
9 Jiutai Jiurui Quantitative Stock Securities Investment Fund Class A Fund 39.85 0.03
10 Changxin Healthcare Industry Flexible Allocation Hybrid Securities Investment Fund (LOF) Class A Fund 19.23 0.01

5. Concept Sectors

  • Biological Vaccine
  • Smart Wearables
  • Pension Concept
  • Gene Concept
  • Smart Healthcare
  • Generic Drugs
  • Mask Protection
  • Helicobacter Pylori
  • Innovative Drugs
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • SME 100
  • SZSE 300
  • SME 300

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information